Blunt Business

Do Utah and the UK Prove Clinical Oversight Is the Future of Medical Cannabis

18 Nov 2026 · 10:05
Management

Description

As daily cannabis use climbs to roughly 1.2 million people in Great Britain (Forbes), retail pharmacy giant Boots is launching its SureLeaf online prescription service across roughly 1,800 UK locations to offer affordable medical cannabis flower and oil starting at £40—a mainstream breakthrough modeled directly on clinical pharmacy integration (MJBizDaily; The Telegraph). This rollout mirrors the clinical blueprint pioneered in Utah, where state law replaces traditional retail "budtenders" with licensed Pharmacy Medical Providers (PMPs) who review patient medical histories, screen for CYP-mediated drug interactions, and guide individualized dose titration (Pharmacy Times; Cannabis Industry Journal). Together, Utah's established framework and the UK's high-street expansion validate a crucial lesson underscored by pharmacy policy experts (Pharmacy Times): embedding licensed pharmacists into regulated cannabis distribution—rather than sidelining them as Canada did (Pharmacy Times)—legitimizes the plant as a safe, standardized therapeutic, protects vulnerable patients, and unlocks sustainable mainstream market growth.



Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Comments

No comments yet — be the first to write one.